1006890-84-1

Basic information

• Product Name: 6-(benzyloxy)-7-methoxy-3-(2.2,2-trifluoroethyl)quinazolin-4(3H)-one
• Synonyms: 6-(benzyloxy)-7-methoxy-3-(2.2,2-trifluoroethyl)quinazolin-4(3H)-one
• CAS NO: 1006890-84-1
• Molecular Weight: 364.324
• Mol File: 1006890-84-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-(benzyloxy)-7-methoxy-3-(2.2,2-trifluoroethyl)quinazolin-4(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(benzyloxy)-7-methoxy-3-(2.2,2-trifluoroethyl)quinazolin-4(3H)-one(1006890-84-1)
• EPA Substance Registry System: 6-(benzyloxy)-7-methoxy-3-(2.2,2-trifluoroethyl)quinazolin-4(3H)-one(1006890-84-1)

Safety Data

• Hazardous Substances Data: 1006890-84-1(Hazardous Substances Data)

Upstream product

• 909912-09-0 benzyl 2-amino-5-(benzyloxy)-4-methoxybenzoic acid 
• 753-90-2 trifluoroethylamine 
• 149-73-5 trimethyl orthoformate 

Relevant articles and documents

HETEROAROMATIC QUINOLINE-BASED COMPOUNDS

The invention pertains to heteroaromatic compounds that serve as effective phosphodiesterase (PDE) inhibitors. The invention also relates to compounds which are selective inhibitors of PDE10. The invention further relates to intermediates for preparation of such compounds; pharmaceutical compositions comprising such compounds; and the use of such compounds in methods for treating certain central nervous system (CNS) or other disorders. The invention relates also to methods for treating neurodegenerative and psychiatric disorders, for example psychosis and disorders comprising deficient cognition as a symptom.